US pharma major Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company ...

(Reuters) -Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives, Dan Lynch, and ...

The American pharmaceutical company Bristol Myers Squibb, together with the venture capital firm Bain Capital, is forming a ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...

Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...

The biopharma spinoff will advance the development of its five investigational therapies designed to treat autoimmune disease.

The 36-year-old Officer Didarul Islam was among those killed. The shooter’s motive is not yet clear. Here’s the latest.

Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...

Park Avenue hosts Blackstone, the world’s largest alternative asset manager, the NFL, KPMG, and Bristol Myers Squibb, among ...

Bristol Myers Squibb is taking a strategic leap, offloading five immunology assets, including three in clinical stages, to a ...